Search by company name or keyword(s)
Companies covered
Our content
Services
About us
Contact us
Edison
Our content
Our content
Search Sectors
All sectors
Cannabis
Consumer
Financials & real estate
Healthcare
Industrials
Investment companies
Metals & mining
Oil & gas
TMT
Search Regions
All regions
Asia - Pacific
Europe
Ireland
North America
RoW
UK
Search Content Types
All content types
Research
Video
Insights
Sparks – Morning News
Regular publications and sector reports
Edison Sparks - Morning News
ReNeuron Group – Continuing to gain clinical data in eye disease
Hepion Pharmaceuticals – First data on liver enzymes encouraging
Carmat – executive interview with Stéphane Piat
Pixium Vision – Pixium Vision to combine with Second Sight
InMed Pharmaceuticals – INM-755 Phase I complete, on to Phase II
Carmat – CE Mark achieved, launching in Q2
CASI Pharmaceuticals – executive interview
Oasmia Pharmaceutical – Clarity on pathway to US approval
Oasmia Pharmaceutical – executive interview
BioLargo – Firing on all cylinders
Immunicum – Potentially transformational merger
BerGenBio – Progressing towards key inflection points
Onxeo – executive interview
Ergomed – MedSource acquisition to boost US CRO business
Targovax – An excellent end to the year
Kazia Therapeutics – Cantrixil final Phase I data reported
Showing 1 - 16 of 1489 pieces
1
2
3
…
94
Browse by content type
Edison Sparks - Morning News
Edison TV
Edison Explains & Themes
Regular publications and sector reports
Research Scheme - Deutsche Börse
Research Scheme - TASE
Cookies
This site uses cookies:
Find out more.
Okay, thank you